Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × Triptorelin Pamoate × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 24 Breast Neoplasms 3 Prostate Adenocarcinoma 1 Neoplasm Metastasis 1 Hematopoietic and Lymphatic System Neoplasm 1

Interventions

pembrolizumab 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Carboplatin 5 Docetaxel 4 Biopsy 4 trastuzumab deruxtecan 3 darolutamide 3 Trastuzumab 3 Platinum 3 Goserelin 3 Cisplatin 3 sacituzumab govitecan 2 pertuzumab 2 entrectinib 2 Leuprolide 2 Ado-Trastuzumab Emtansine 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 trastuzumab biosimilar HLX02 1 spartalizumab 1 selinexor 1 pyrotinib 1 luprolide acetate gel depot 1 lenvatinib 1 larotrectinib 1 enfortumab vedotin 1 dehydroftorafur 1 ceralasertib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡